Alan is a senior staff clinical research scientist in Google Health who leads the clinical team’s translational research efforts, with a particular focus on bridging new ML developments and health-oriented research. He focuses on machine learning for medical imaging across multiple fields: radiology, ophthalmology and dermatology, with interests in AI safety, robustness and data-efficiency for realising real-world clinical impact. Alan is an honorary Lecturer in Vascular Surgery at Imperial College in London where he continues to see patients and supervise PhD students. He did his MA in Neuroscience and Medical Degree (MBBChir) at the University of Cambridge, followed by specialist training in surgery in the London Deanery, where he completed his Membership of the Royal College of Surgeons (MRCS), PhD in Vascular Surgery and was appointed as a NIHR Clinical Lecturer. In 2017 he joined DeepMind’s health research team and in 2019 joined Google Health. He has published over 150 peer-reviewed articles, including first-author studies in the New England Journal of Medicine and The Lancet prior to DeepMind/Google, where he subsequently co-authored landmark papers in Nature and Nature Medicine on deep learning systems for mammography, ophthalmology and electronic health records.

I am a Consultant Obstetrician subspecialising in Fetal Medicine and abnormally adherent and invasive placenta (placenta accreta spectrum disorder). I graduated in Clinical Medicine from the University of Oxford and trained within the Oxford Deanery. During my training I completed a Doctorate in Obstetric Ultrasound here in the Nuffield Department of Obstetrics and Gynaecology.

I have a weekly high risk obstetrics ante-natal clinic at the Horton Hospital in Banbury and also lead the FMU Placenta Clinic which provides a tertiary referral service to the Thames Valley region and beyond.

I co-authored both national (RCOG) and international (FIGO) guidelines for the classification, diagnosis and management of abnormally invasive placenta (AIP: now called placenta accreta spectrum, PAS) and am the lead author on the IS-AIP evidence based guideline for intra-partum management of AIP. I am also working with NHS England to develop a national network for the improved management of PAS. I represent the UK to and am elected Vice Chair of the International Society for PAS (IS-PAS) and an elected representative to the European Placenta Group Committee.

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

Allison lectures at Keele University in Data Science and is a co-founder of Women Leading in AI, CEO of AI Aware and ForHumanity Fellow. Her research is focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI and health tech. She works on the IEEE P7003 Considerations of Algorithmic Systems and with the ISO and BSI on AI linked standards, sitting on the UK national committee for ART/01 Artificial Intelligence standards and on CEN-CENELEC JTC21. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant on the ethical design of autonomous and intelligent systems offering training and AI bias audits/AIAs.

Danny is the AI Clinical Lead at the Guy’s Cancer Centre, which is partnering with the newly established AI Evaluation Unit at the King’s Technology Evaluation Centre (KiTEC), King’s College London, on the clinical evaluation of AI technology in cancer care.

Danny has formerly held posts as Director of Public health for the London Borough of Lewisham and the City of Newcastle, and as Senior Lecturer in Epidemiology and Health Services Research at Newcastle University and Dundee University. Danny has developed national clinical guidelines for the NHS in Scotland, conducted large randomised trials, and developed Patient Reported Outcome measures recommended by the US FDA, used with patients across the NHS in England and throughout the world. 

Debashish is a Consultant Cardiologist at Barts Hospital NHS Trust with a passion and history of service improvement within the NHS. The passion Debashish has for digital health led him to to develop a virtual clinic platform (Ortus-iHealth). The goal was to combine virtual consultations, a patient portal and patient reported outcome measurement (PROMs) generation into one easy to use platform.

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer EMEA for GE Healthcare, a $17 billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe, the Middle East & Africa. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products

Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’ previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies.

Mathias holds a medical degree (MD) from the University of Bochum, Germany. He has been secretary general of the German Chinese Society of Medicine, Berlin, from 2005 – 2019.

Alastair Denniston is a consultant ophthalmologist (eye specialist) at University Hospitals Birmingham leading research into the use of health data research and artificial intelligence to improve patient care in the ‘real world’. He is Professor at the University of Birmingham, and part of the Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital/UCL.

Alastair has particular interest in how we can ensure that the innovation within the broad field of ‘artificial intelligence’ is translated efficiently but safely to benefit patients. This includes improving the reporting standards of trials (CONSORT-AI and SPIRIT-AI), helping define the regulatory framework for AI in healthcare, and working with HDRUK and other relevant organisations to support the best of these innovations right through the implementation pathway.

He is Director of INSIGHT, the HDRUK Health Data Research Hub for Eye Health which is focused on eye disease and its application to wider health, including diabetes and dementia. It will use anonymised large-scale data and advanced analytics, including artificial intelligence, to develop new insights in disease detection, diagnosis, treatments and personalised healthcare.

Dr Xiao Liu is a specialty trainee in ophthalmology in the West Midlands Deanery and a clinical researcher at the Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

Her doctoral research is around the validation of instrument-based technologies for detecting and quantifying inflammation in the eye. She is working with Professor Alastair Denniston’s team to develop a new technique based on optical coherence tomography (OCT), a non-invasive retinal imaging device, for the assessment of vitreous inflammation in uveitis.

Dr Liu has particular interests in applications of machine learning in healthcare. Her work is based around diagnostic test evaluation (including machine learning algorithms as tests) and improving reporting standards for machine learning interventions in clinical studies. She co-led the SPIRIT-AI and CONSORT-AI initiative, new international standards for reporting of clinical trials.

She has a number of advisory roles, including as a member of the WHO/ITU Working Group for Regulatory Considerations for AI in Health and as a member of the NHS AI Lab Evaluation Advisory Group for the AI in Health and Care Award. Dr Liu is also an honorary research fellow under the Artificial Intelligence hub at Moorfields Eye Hospital Reading Centre in London and with INSIGHT, the HDR UK data hub for eye health.

Ian is actively involved in the NIHR i4i Programme, SBRI Healthcare and now the AI in Health and Care Award along with Medtech SME engagement, managing a portfolio of funded projects and the NIHR Innovation Observatory contract. A DPhil in chemistry led to Ian becoming a Principal Scientist at Kodak European R&D, followed by 9 years at GE Healthcare leading the Discovery portfolio for neurological molecular imaging. Ian is a (co-)inventor on 38 patent applications, a Fellow of the Royal Society of Chemistry, a member of UKRI Peer Review College and the External Review Board for CPI Photonics.

Born in the UK, Amy has always  had a strong passion for people and places. She left the UK 13 years ago and moved to Amsterdam, onto Hong Kong, and then back to where she calls home, Amsterdam. 

With 20 years of marketing, human insights and strategy experience, Amy is now fully enjoying her ‘second life’ at Philips.  The brand’s mission to improve the lives of 3 billion people by 2030, sits very close to Amy’s heart.  Amy believes she is in a fortunate position to be able to work on ways to make healthcare more accessible, more centred around the individuals involved, and more impactful in terms of facilitating timely diagnosis, emotional and physical care, and rehabilitation Vs. (re) admissions.

Tim is a tech entrepreneur from the Cambridge Cluster, passionate about using AI to accelerate treatments for rare diseases. He is the Co-Founder and Chief Executive of Healx, the mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. In this role, Tim has been listed in The Sunday Times Maserati 100 list of entrepreneurs in 2019, was featured in The Telegraph’s Tech 100 in 2019, and was named one of In Vivo’s 30 Rising Leaders in the Life Sciences in 2020. He was also named as ‘One to watch’ in The Telegraph’s Top 50 Most Ambitious Business Leaders in 2020.

Tim is also the Co-Founder and Trustee of the Cambridge Rare Disease Network (CRDN). Prior to Healx and CRDN, he obtained his PhD at the University of Cambridge in the field of Biophysics and Neuroscience, developing nanobody technology for Parkinson’s disease. Before moving to Cambridge UK, Tim obtained an MEng in Bio- and Chemical-Engineering from the University of Brussels.

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally.

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money 2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

Nick Taptiklis, Head of Technology Strategy at Cambridge Cognition 

Nick is Head of Technology Strategy at Cambridge Cognition. He has 20 years software engineering experience, with a background in the translation of academic research into successful commercial products.

Nick joined Cambridge Cognition to launch CANTAB Mobile, an EU & FDA certified dementia screening tool for primary care. Nick went on to lead the development and deployment of mobile and wearable cognitive assessments in the context of pharmaceutical trials.

Since 2016 Nick has co-led R&D at Cambridge Cognition, most notably developing the NeuroVocalixTM platform for automated administration and scoring of voice-based cognitive assessments.

Nick has also been involved in several industry and academic research collaborations exploring novel digital biomarkers related to neurological and psychiatric disease.

Tara Donnelly is the interim Chief Digital Officer at NHS England.

She oversees a portfolio of citizen facing digital services, including the NHS website, NHS App and the development of digital services which meet people’s needs, target prevention and offer a personalised experience.

Tara is on secondment from her role as Chief Executive of the Health Innovation Network. She has led the Health Innovation Network for over three years and is also a non-executive director at the Nuffield Trust.

She has an extensive background in leadership roles within the NHS and the voluntary and community sector and has spent the past 18 years at board level. She has worked in the NHS for 30 years, with her first role being as a Ward Housekeeper when she was 18.

Alan is a senior staff clinical research scientist in Google Health who leads the clinical team’s translational research efforts, with a particular focus on bridging new ML developments and health-oriented research. He focuses on machine learning for medical imaging across multiple fields: radiology, ophthalmology and dermatology, with interests in AI safety, robustness and data-efficiency for realising real-world clinical impact. Alan is an honorary Lecturer in Vascular Surgery at Imperial College in London where he continues to see patients and supervise PhD students. He did his MA in Neuroscience and Medical Degree (MBBChir) at the University of Cambridge, followed by specialist training in surgery in the London Deanery, where he completed his Membership of the Royal College of Surgeons (MRCS), PhD in Vascular Surgery and was appointed as a NIHR Clinical Lecturer. In 2017 he joined DeepMind’s health research team and in 2019 joined Google Health. He has published over 150 peer-reviewed articles, including first-author studies in the New England Journal of Medicine and The Lancet prior to DeepMind/Google, where he subsequently co-authored landmark papers in Nature and Nature Medicine on deep learning systems for mammography, ophthalmology and electronic health records.

Dr. Wei Fan is the executive director of Tencent Hippocrates Labs. His main interests are in using various artificial intelligence techniques-based digital therapeutics & digital biomarker for clinical problems, such as motion disorder syndrome (e.g., Parkinson’s disease), cancer radiotherapy planning, heart failure early detection, etc. Dr. Fan received Ph. D. in Computer Science from Columbia University. He has been working in AI since 1995. He has over 150 top journals and conference papers with h-index of 58. He has received multiple best paper awards in top AI conferences and competitions. He served as the associate editor of ACM Transaction on Knowledge Discovery and Data Mining.

Hadas Bitran is Head of Health & Life Sciences at the Microsoft Israel R&D Center.

Hadas and her group focus on building AI technologies and solutions for the healthcare domain, including language services, natural language processing technologies, conversational intelligence and personal health assistants.

During her career in Microsoft, Hadas has been developing products in the areas of healthcare, personal assistants, recommendation systems, online advertising and consumer privacy. Her work has been shipped as part of Cortana, Bing and the Windows Operating System.

Before Microsoft, Hadas held senior leadership positions managing software R&D and Product groups in corporates and in start-up companies.

Hadas received her B.Sc. degree in Computer Science from Tel Aviv University, and her MBA from Kellogg School of Management, Northwestern University in Chicago.

Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer EMEA for GE Healthcare, a $17 billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe, the Middle East & Africa. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products

Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’ previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies.

Mathias holds a medical degree (MD) from the University of Bochum, Germany. He has been secretary general of the German Chinese Society of Medicine, Berlin, from 2005 – 2019.

Dr Indra Joshi is the Director of AI at NHSX and runs the NHS AI Lab – a £250m programme to accelerate the safe adoption of ethical and effective AI-driven technologies to the front line of health and care. 

Indra has a unique portfolio with experience stretching across digital health, data and AI strategy and delivery; whilst remaining true to her professional training as an emergency medic.   

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skillsets and disciplines in health technology. Alongside she is an associate editor for BMJ Leader, a member of the WHO digital health expert group, a consultant on digital health, and most importantly a mum to two wonderful little munchkins.

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry.  Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.

Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.

Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

Samantha Roberts has recently been appointed as Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement.

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA and joining McKinsey and Company, where she worked in a wide range of industries before specialising in healthcare.

After McKinsey she moved into the NHS as a senior manager at a large teaching hospital in London (UCLH) and a director in an Academic Health Sciences Centre and Network (UCLPartners). Before taking on the role of Director of Innovation, Research and Life Sciences at NHS England and NHS Improvement last year.

Over the last five years she has become involved in research, working with health economic models to inform evidence-based policy, initially at the London School of Economics before moving to the University of Oxford to undertake a DPhil (PhD).

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

Christina is an innovation senior manager at NHS England and NHS Improvement. After working for many years as an adult nurse specialising in critical care, Christina moved to a quality improvement and patient safety role in an acute Trust, particularly developing the Women and Children’s service. In 2018 Christina joined the Innovation, Research and Life sciences team supporting innovation programmes which challenge traditional ways of working to improve patient care. Christina’s MSc in Implementation and Improvement Science and recent work have led her to focus on the factors which affect successful adoption and spread of innovation into healthcare, covering a wide
range of innovations including MedTech, diagnostic, digital and AI solutions. Christina leads the AI Award delivery team: the team supports the AAC ambition to improve the pipeline for innovations which meet the needs of patients and the National Health Service.

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data. This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

Danny is the AI Clinical Lead at the Guy’s Cancer Centre, which is partnering with the newly established AI Evaluation Unit at the King’s Technology Evaluation Centre (KiTEC), King’s College London, on the clinical evaluation of AI technology in cancer care.

Danny has formerly held posts as Director of Public health for the London Borough of Lewisham and the City of Newcastle, and as Senior Lecturer in Epidemiology and Health Services Research at Newcastle University and Dundee University. Danny has developed national clinical guidelines for the NHS in Scotland, conducted large randomised trials, and developed Patient Reported Outcome measures recommended by the US FDA, used with patients across the NHS in England and throughout the world. 

An innovative operational strategy expert with extensive and wide-ranging experience relating to strategic programme leadership, planning and management of clinical trials with responsibility for global clinical programmes (US, Europe and Japan). Peju started her career working in early drug discovery and exploratory phase focused on the transition of early stage assets to clinical development. Following this, she moved into programme management of late stage assets responsible for key clinical programmes within Eli Lilly, Sanofi Aventis, Pfizer and Takeda before joining BenevolentAI as Clinical Development Operations Leader.

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

Neil is an Information Management professional by background and spent over 25 years in the NHS running clinical information systems to support operational Trust activity. 

Since moving into independent management consulting in 2011, Neil has undertaken a number of service reviews of IM&T/Informatics functions to ensure alignment between service delivery and organisational strategic/operational priorities. 

He is passionate about the role technology can play in improving healthcare delivery and has led many successful national and locally driven IT-enabled change management programmes and projects, to support significant improvements to healthcare delivery. 

Neil is interested in the development of interoperability between IT systems across Healthcare sectors and better use of information in support of healthcare delivery redesign.

Neil qualified with a Psychology Degree at Leicester university then completed a Postgraduate qualification in AI. 

In addition to his management consulting roles Neil is a Non-Executive Director for the South West Academic Health Science Network and for Stalis Ltd – who specialise in data management in the health and social care setting.

He is also the Managing Director for a company that was established to carry out research into the early identification of people with liver disease, supported by a 3-year grant (£1.5m) from the NIHR.

Paul Singer is CCIO Bedfordshire, Luton & Milton Keynes, GP Luton and a failed skier & scuba diver!

Paul believes, integrating data across systems needs to be paralleled by effective curation of records or else we become overwhelmed by information often lacking accuracy and context so that faced with a patient neither they nor we can easily recall when they had that knee replacement or exactly why. We need to be thinking at an early stage of how we derive accurate and timely information from the mass of data which is collected through integrating health and care records at any level.

Some of this can be achieved through careful organizational curation but there will also be a need to develop intelligence in evolving record sharing so that at the point of care we can be presented with relevant, contextual information which supports safe and efficient care processes and the wood is stacked up as we walk through the trees.

Jenny Muir is currently the Chief Nursing Informatics Officer (2018-present time) at a London Trust, having previously worked in several senior clinical, educational and corporate roles within the NHS.  These roles have enabled her to develop my nursing, leadership and management skills, along with other transferable skills relevant to the fast-paced and rapidly evolving healthcare landscape. She is required to provide expert professional advice, develop strategies and implement policies to assure the quality and safety of nursing, midwifery and AHP practice.

Within her current role she has acted as the nurse lead for the implementation of electronic clinical documentation (including electronic Prescribing and Medicines Administration – ePMA) within inpatient, outpatient and theatre settings. This process has required robust project and change management skills and the ability to collaborate closely with other colleagues across the trust along with external agencies.

Sid Singh is an NHS Consultant Urologist in the middle of England but wears other hats.  As the Chief Clinical Informatics Officer at his hospital, he leads the clinical informatics department. He is responsible for developing the Clinical IT strategy and driving its implementation. There are various digital initiatives that he is involved with as part of the digital transformation that the hospital is going through. 

Sid has completed a post-graduate diploma in Digital Health Leadership, a flagship programme of the National Health Service (NHS), UK designed to equip the clinical informatics leaders to lead and drive the imminent digital transformation in the NHS.  

Sid has initiated a new Clinical Informatics training programme aimed at delivering core competencies required for the clinical informatics leaders in his hospital. A curriculum is being developed using the competency requirements from both the North American and UK Clinical Informatics professional organisations. 

Sid is faculty at Warwick Medical School and regularly teach medical students and trainees. He is involved in collaborative academic health IT projects with the aim of generating high impact publications and creating a hotbed of innovation at the interface of industry, academia and the public sector.  

Reet Johal is a Consultant Obstetrician and Gynaecologist, with a special interest in Minimal Access Surgery. She is the Chief Clinical Information Officer at the James Paget University Hospital and started in this role in June 2020. Their Integrated Care System is embarking on a journey to jointly procure an electronic patient record solution, to allow joined up patient care at the three acute hospitals as well as primary and community care. In addition, they have an extensive digital transformation programme being undertaken at trust level, looking at digitalisation of observations, test requesting and results management; and streamlining login processes with single sign on. Having worked in the NHS for 13 years, Reet is very excited about the journey of digitalisation, and loves the challenge of managing change.

Shauna is currently the Chief Information Officer & Executive Board member at Northern Lincolnshire & Goole NHS Foundation Trust (NLaG).  Prior to joining the Trust, she was a Partner in Digital Transformation Consulting at South Central & West CSU.  Having worked in the Canadian Healthcare system for many years, she came to the UK in late 2015 to join Frimley Health as their CIO.  Shauna is passionate about the positive impact effective digital transformational can have in the health and care system. As a leader she is grounded in the belief that healthy relationships with people are key to success, in combination with a positive attitude to lead and coach teams to achieve and exceed results, goals and targeted deliverables. This is combination with attention to continuous learning are critical components of being a successful digital Leader.

Sam is currently the Chief Clinical Information Officer at North West Ambulance Service. He has a keen interest in patient flow across both the internal service lines of patient transport, NWAS111 and the NWAS Paramedic Service and how this links with the wider health economy. He is currently working on projects to share information at a regional and local level to assist frontline resources access digital care records to reduce ambulance transport and improve patient experience and outcomes. His career in the NHS has seen him work in a number of care settings including international experience with the Qatar national ambulance service. He also has a wealth of experience in working in commercial settings having produced and delivered health focussed training to Industry leaders such as British Aerospace, Exxon Mobile and Wilkinson Hardware. He holds a Master’s degree in Advanced Practice and is a visiting lecturer at several British Universities.  Sam aspires to bring the wealth of experience to the digital role with an emphasis on digital first and artificial intelligence to provide live sense checking and feedback from the use of digital triage tools.

Dr John McCormick is a GP partner in South Devon and Chief Clinical Information Officer for Devon Integrated Care System. John has led the successful roll out of online consultations in primary care over the last few years and has developed an in-depth understanding of the challenges faced when implementing and optimising this type of technology at scale. He has recently completed an MSc at the NHS Digital Leadership Academy. John is currently the chair of the South West CCIO/CIO network.

Lee Rickles is a member of the CIO advisory board, a CHIME Certificated Health Chief Information Officer and alumni of the Digital Academy.  

He has three decades transformation and programme management experience.  His first decade focused on UK military aircraft project for the T-45 Goshawk, Sea Harrier, AV-8B and Nimrod.  During the last two decades, he has focused on digital transformation in the NHS, Information Technology services and Business Intelligence for NHS organisations. Lee has also had significant experience in the development of change strategies; digital developments and procurement of Information Technology Services and systems.

He is currently is leading the development of the Yorkshire & Humber Care Record, Digital transformation of Humber Coast & Vale ICS and the CIO of Humber Teaching NHS Foundation Trust.

Robert qualified in engineering and medicine at Cambridge and Oxford Universities.  He became a consultant chest physician in 2004 and was CCIO at Gateshead Hospitals from 2008.  He certified as a leader in Lean in 2013 in collaboration with Virginia Mason Medical Centre of Seattle.  He uses lean principles for the application of digital systems with the aim to eliminate wasted time and non-value activity in order to reduce cost, improve safety, and to provide excellent patient experience.  He is a graduate of the North East Leadership Academy.  Gateshead Hospital is now rated Outstanding by the CQC and is a fast follower in the Global Digital Exemplar program.  In August 2020 Robert relocated to Gloucestershire (for love) and now works in role of CCIO for Gloucestershire Hospitals Trust.

When not trying to understand value streams or designing better systems in hospitals, Robert loves climbing mountains, cycling, skiing and running –all of which his sons remind him how much faster they are. He plays the clarinet and has a fondness for musical theatre.

Javier has devoted his career to the fields of Marketing and Business Development. During the early years of his working life, he developed his professional skills in the Marketing area of renowned companies of the Food & Beverage industry. Afterwards, he moved to Business Development, where he quickly jumped to the international scenario, managing corporate sales in different continents. By 2017, he was managing Sales Department at a multinational company for the whole African Continent.

In 2017, Javier founded IOMED together with two other business partners. At IOMED, Javier has been CEO, managing the company’s strategy, business development, public relations and investors’ relations.

Ian is actively involved in the NIHR i4i Programme, SBRI Healthcare and now the AI in Health and Care Award along with Medtech SME engagement, managing a portfolio of funded projects and the NIHR Innovation Observatory contract. A DPhil in chemistry led to Ian becoming a Principal Scientist at Kodak European R&D, followed by 9 years at GE Healthcare leading the Discovery portfolio for neurological molecular imaging. Ian is a (co-)inventor on 38 patent applications, a Fellow of the Royal Society of Chemistry, a member of UKRI Peer Review College and the External Review Board for CPI Photonics.

A former Darzi Fellow, Fay joined the Health Innovation Network from the London Ambulance Service where she was employed as Paramedic team leader, before which she has worked as a physiotherapist and gained a MSc in Healthcare Leadership at King’s College London. Fay’s HIN portfolio is primarily concerned with the promotion of healthy living and the prevention of illness and disability affecting older people. She is leading on the NHSX Innovation Collaboration for London which sees the London STPs/ICSs supporting the implementation and evaluation of remote monitoring in care homes across the capital.

Professor Gilbert is Head of Department of Radiology at the University of Cambridge. Her clinical work and research is focused on imaging techniques relating to breast cancer and oncology.  She is interested in multimodal functional imaging with MRI and PET of the tumour environment using breast cancer as a model and correlating this with the tumour genetic profile.  She undertakes research in stratified breast screening using Abbreviated MRI, Tomosynthesis, Whole Breast Ultrasound and Contrast Enhanced Mammography. She maintains a strong interest in musculo-skeletal imaging.  She evaluates new imaging technology and is currently working on Artificial Intelligence in Imaging. 

Since 2012 Professor Gilbert has been awarded fifteen competitive grants worth over £20M. She was a member of the NIHR HTA Board and then the EME Board and is on a number of advisory panels.

Professor Gilbert has 236 peer reviewed publications, 5 book chapters and numerous conference abstracts.   She is a regular speaker at international Radiology conferences in Chicago and Vienna and is current President of the European Society of Breast Imaging and was awarded the Gold Medal from the European Society of Radiology in 2021.

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

Dr Marc Farr started his career at Experian, where he was head of public sector consulting. He went on to become head of development at Dr Foster, and has been director of information at East Kent Hospitals University NHS Foundation Trust for seven years. He is also founder and chief executive of Beautiful Information.

Beautiful Information is a first of kind NHS / private partnership, that delivers real time information to NHS trusts to help them plan and resource clinical services. It’s vision is to connect patients, clinicians and managers through beautiful information, to make healthcare simple and transparent.

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

Erik de Heus has been at the helm of SkinVision as CEO since 2017. With over 20 years of global experience, Erik has both the breadth of experience and proven knowledge to drive the health tech company’s mission forward.

Throughout his previous work within Hewlett-Packard and Royal Philips Electronics, he has experience building new products and services with a global scope. For Hewlett-Packard, he worked and lived in Geneva and Mountain View. In various management positions, working across cultures with different corporate and entrepreneurial teams, he created and managed different solutions in the technology, finance, services, health, and wellbeing spaces.

In addition to this global experience, Erik was CEO of a Dutch renewable energy company Oxxio. Under his management, the company grew in the timeframe from inception to generate over € 500,000,000. In the buy and build strategy, Oxxio acquired and integrated four companies in two years. OXXIO was acquired in 2005 by Centrica Preventing an IPO planned for mid-2005. Erik holds a Master degree in Business Economics from the Free University of Amsterdam.

Kevin Goodwin is a 32 year veteran innovator from the global ultrasound business. In 1998 he founded Sonosite, the world’s first ultrasound company to miniaturize & simplify ultrasound technology. Today, Kevin is engaged in another first: applying artificial intelligence to recognize anatomy and quickly guide medical practitioners of all skill levels in easily looking into the body, and to make more accurate diagnostic assessments in just seconds. In 2015, Kevin co-founded EchoNous for the purpose of creating intelligent medical tools with extremely miniaturized, diagnostic grade technology.

John manages the clinical aspects of the company’s operations including legislation, information governance, clinical safety and ensuring TPP’s products reflect the latest medical practice.

Dr Parry graduated from the University of Cambridge with a medical degree in 1980. He moved to Yorkshire in 1984 to take a position as a partner of Keighley Health Centre, specialising in oncology and palliative care. He was an early user of SystmOne and recognised the benefits clinical IT could bring to the delivery of patient care. As a result, Dr Parry took the role of clinical lead at TPP, directing the clinical aspects of all products throughout the development process. He holds relationships with leading medical representatives around the country to make sure TPP’s company priorities align with those of the wider clinical community. John became a Director in 2007 and now leads a team of expert clinicians, ensuring TPP’s products meet the requirements of health services.

Dr Parry’s expertise as a healthcare specialist is nationally recognised. He is a member of various high-level committees, including the TechUK Health and Social Care board. As a leading clinician, he is frequently invited to give keynote speeches on a wide range of topics, including information governance and the role of IT in patient care.

Jenny started her career in the NHS as a Graduate Management Trainee, and since then has held a number of operational and strategic roles in the NHS and overseas. Before joining the Accelerator, Jenny was the General Manager for Women’s Services at Guy’s and St Thomas’ Hospital.

Jenny has an MBA from the London Business School and a Masters in Healthcare Management from Manchester Business School.

Dr Rayna Patel is a medical doctor & neuroscientist with an MPhil in Translational Medicine. She has extensive experience in academia (Cambridge, Harvard, MIT, Columbia) and was an Associate Fellow of Clare Hall College, Cambridge. Rayna has subsequently held strategic & commercial roles in government policy, tech startups & the Cabinet Office’s Nudge Unit, where she used behavioural science to rewire patient behaviours through digital products.

She is currently CEO and Co-Founder of Vinehealth, a digital platform using a combination of behavioural science and AI to improve the quality of life and survival of cancer patients, whilst generating crucial real-world data to better inform healthcare delivery and drug development.

Peter Mountney PhD is CEO of Odin Vision.  Odin Vision is a UCL spin out, using artificial intelligence (AI) to improve the detection and diagnosis of cancer in gastroenterology. The award-winning company was named as one of the top UK AI companies to watch and has two regulatory approved AI products on the market. Peter carried out his PhD and post-doctoral work at Imperial College London before joining Siemens Healthcare where he led AI programmes of research and development across a wide range of clinical applications. He is an Honorary Associate Professor at University College London, a Fellow of the Royal Academy of Engineering Enterprise Hub and a member of the Royal Society Industrial College. 

Elina Naydenova is a biomedical & AI engineer, with a PhD in Machine Learning for Healthcare Innovation from Oxford University. She is the CEO & co-founder of Feebris – a company whose AI-powered platform enables carers & community health workers to detect health conditions early. She was named Female Entrepreneur of the Year (2020) by Giant Health and Innovator of the Year (2020) by Giant Health.

Kassandra Karpathakis is Head of AI Strategy for the NHS AI Lab, NHSX. Kassandra provides strategic direction across the Lab’s portfolio and is passionate about building international partnerships to share expertise in health AI. Her other responsibilities include overseeing policy research projects with a focus on evaluation of health AI.

Prior to this, Kassandra was Public Health England’s Digital Strategy Lead and a founding member of a health tech start-up. Kassandra consistently demonstrates her passion and expertise for bringing together different communities of professionals and users to create and deliver digital health projects. 

Kassandra leveraged these skill sets within PHE’s COVID-19 Guidance Cell to create a new cross-government COVID-19 guidance production process, to ensure high-quality guidance reached the public in a timely manner, and to keep the wheels on the bus turning at times of high pressure. 

Kassandra is also recognised on the World Health Organization’s (WHO) Roster of Digital Health Experts. She is currently an expert lead on evaluation of health AI for the International Telecommunications Union (ITU) and WHO Focus Group on AI for Health. 

Kassandra is originally from Perth, Western Australia, where she studied physiology, anthropology and philosophy at The University of Western Australia. 

Alan is the Director of Innovation Programmes and Partnerships within the newly established Innovation, Transformation & Digital Directorate. 

Alan’s responsibility at Health Education England is to establish and build collaborative partnerships and explore the spread of new workforce programs between system partners (at national, regional and local level) and Health Education England. His areas of interest & responsibility span the directorate including workforce transformation, digital readiness, XR/VR/immersive learning, patient safety, genomics and AI & robotics. 

Prior to joining Heath Education England, Alan was the Director of Digital Health for the Innovation Agency (NWC AHSN) / ex-Deputy-Chair of the Digital & AI INN (the AHSN Network); he led on strategic digital themes across the AHSN Network, sat on his two respective ICS/STP digital boards and was a member of steering groups for high profile pieces of work including the NHS Empower the Person, NICE DHT Evidence Standard Framework and the HEE led Topol review. 

Alan also works and is a regular technology assessor / judge for the NIHR/NHSx/AAC AI Lab (Ph 3 and Ph 4), TSA, HSJ and EPSRC bodies.

Alan’s preceding roles to joining the Innovation Agency include strategic exec directorship roles in the multinational MedTech / assistive technology industry (Philips & Tunstall Healthcare) and prior to that had a long career in multinational management consultancy (Partner PA Consulting, PwC and Gemini Consulting). 

Dr Emma Hughes is the Evaluation Lead for the AI in Health and Care Award, which is a £140m fund managed by the Accelerated Access Collaborative that will accelerate the testing and evaluation of the most promising AI technologies that meet the strategic aims set out in the NHS Long Term Plan. The Award is split across four phases of maturity of the AI technologies and independent evaluations are being commissioned for the most mature to inform their onward adoption and scaling. The execution of these evaluations will provide practical learnings on how to conduct AI evaluations in real-world NHS settings, informing NICE and PHE evidence standards. Emma comes to the Award with experience of digital health and real-world evaluation from her work on the NHS Test Beds programme and leading the evaluation strategies for the Clinical Review of Standards and Rapid Diagnostic Centres. Prior to the NHS Emma worked in a range of settings across academia, the pharmaceutical industry, and charity research funding.

Through her career, Julia has been involved in the development and application of cutting-edge quantitative methodology across broad range of projects including Real World Data (RWD) and experimental trials. Combination of consultancy skills, ability to see a bigger picture, strong quantitative background, and interest to address business and real-life problems helped Julia to apply modern methods in UK academia and pharma environment. Her most recent experience includes diagnostics in Radiology, application of quantitative methods in RWE and digital health area. She is a current chair of Data Science Special Interest Group (SIG) in Statisticians in the Pharmaceutical Industry (PSI) organisation and is passionate about building up communication bridges between various communities involved in Data Science activities.  

Sreeram (Ram) Ramagopalan is the Global Head for Real World Evidence for Market Access at Roche. Dr Ramagopalan’s team strategically plans and executes real world research studies to obtain and maintain access for Roche medicines. Dr Ramagopalan holds a PhD in Epidemiology from the University of Oxford, as well as an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. He is an international expert in real world evidence with over 275 peer reviewed publications.

MD from Seth GS Medical College and KEM Hospital India with a post – graduate in Pharmaceutical Medicine from University of Surrey ,UK

Has over 15 years experience in Country and Regional Medical Director roles in therapy areas such as Oncology, Diabetes across Emerging countries in Asia Pacific, Middle East, Afrika, Russia and Latin America.

Currently responsible for leading Medical strategy and function in AstraZeneca Middle East and Afrika and involved with AstraZeneca Vaccine Launch and Readiness Project.

He has been member of Education committee of Faculty of pharmaceutical Medicine from  2011-2018

Dr Nick West is the Chief Medical Officer and Divisional Vice-President of Global Medical Affairs of the Vascular Division at Abbott, a global medical device company developing life-changing technologies to reduce the burden of cardiovascular disease and improve patients’ lives. He graduated in medicine from Trinity Hall, University of Cambridge and St. Thomas’ Hospital Medical School, London, and trained in interventional cardiology at the John Radcliffe Hospital, Oxford and Green Lane Hospital, Auckland, New Zealand. His postgraduate research in vascular biology, undertaken in the Department of Cardiovascular Medicine, University of Oxford and at Duke University, led to the award of the Sir Lionel Whitby Medal and the Sir Walter Langdon-Brown Prize at the University of Cambridge. Until late 2019 he was a practicing interventional cardiologist at the Royal Papworth Hospital, Cambridge, UK; he has published over 120 peer-reviewed papers & book chapters on topics including coronary physiology/microvascular function, intracoronary imaging/vulnerable plaque detection, acute myocardial infarction and use of bioresorbable scaffolds. He was also a founding member and latterly Chief Medical Officer of the Cambridge-based biotechnology startup, PlaqueTec Ltd.

Sarantos Kaptanis is a Global Development Medical Director in Late Oncology Research and Development, working for AstraZeneca. Sarantos trained in Greece (Athens) for his MD, JD and Masters degrees and moved to the UK to further his surgical training in general, breast and plastic surgery. He obtained postgraduate qualifications in health research, education and leadership there. At Barts Cancer Institute (Queen Mary, University of London) he investigated the role of breast cancer heterogeneity on outcomes, looking at overall survival and ctDNA levels after surgery for breast cancer. He has co-authored and contributed to several publications and led a surgical research collaborative.

Tommy is currently an Associate Medical Director at Galapagos Biotech, specialising in inflammatory disease. He has worked in the pharmaceutical industry since 2016, previously employed by Gilead Sciences and Bayer. He has a background in clinical medicine and was a doctor in the NHS. He has spent time in clinical research. His thesis was creating novel medical devices in the treatment of oncology. He holds an MBA and is a mentor for varies healthcare start-ups.

Experience Profile: A leader in the Digital application of Real World Evidence (RWE) and advanced analytics (AA). An epidemiologist (MSc), Software Engineer (BSc.), Health economist (pgCert) and applied medical, mathematical modeller (Dphil, MPhil) with over twenty years in the healthcare field. Currently at BMS-leading in real-world evidence, advanced analytics and field-based pathway redesign. Resulting in expertise in the generation, collection, assessment and use of data using traditional and novel analytic methods. >100 peer-reviewed publications and international presentations of data and research. Leading the delivery of multiple concurrent work streams concerned with the assessment of the impact on treatments on market access & pathway capacity

Sabine joined Roche in 2006 as Translational Medicine Leader in early development covering molecules in metabolism and ophthalmology, then moving to the innovative Pediatric Oncology Drug Development team (iPODD) in 2014, where she was the Clinical Science Leader for the pediatric development of Avastin, Cobimetinib and Hemlibra. In 2017 she joined PD Neuroscience, where she acted as Global Clinical Development Team Leader for Olesoxime and most recently Clinical Science Leader for Risdiplam in Spinal Muscular Atrophy. In July 2020 she joined the Personalized Health Care (PHC) Safety Interface team within Roche, a team that works to better understand patient-centric drivers of response to optimize the benefit/risk balance of medicines and drive precision medicine within Roche.

Sabine is a board certified pediatrician with speciality in pediatric diabetology from the University of Erlangen/Germany. She has over 19 years of experience in drug development in the pharmaceutical industry, including strategic roles in both early and late clinical research and medical affairs.

When not at work, Sabine enjoys time with her family and her 10 year old daughter, biking the Black Forest and playing the violin.

A surgeon by training and entrepreneur by mindset, he heads up Human Risk Management (Medical Safety) at Reckitt where he overseas end to end risk management across products in Health, Hygiene and Nutrition. His interest being safety by design and safety as competitive advantage.  

Being a digital health researcher and entrepreneur, he is a mentor and heads up research at a digital health company iKure (Honorary). He is interested in the use of Data Analytics and AI/ML for social good with particular interest in healthcare delivery. 

Apart from the use of modern technology in product safety, he is also interested in usability engineering and user experience in product design.

His key qualities are leadership, communication, and in-depth medical knowledge. He has worked in Medical Affairs, Medical Marketing, Pharmacovigilance and is an expert in both Medicines and Devices.

His Alma Maters include University of Calcutta (Medicine and Surgery), Royal College of Physicians and Surgeons of Glasgow, Harvard Business School (Medical Innovation), University of Oxford (Health Economics) and Rice University (Digital Health).

He is also an arts entrepreneur and works at the interface between western and Indian classical arts.

Dr Imran Lodhi is currently Global Head for Regional Medical Affairs Health team at Reckitt.

After working in the NHS for several years, the Industry experience includes regional and global roles in both medical affairs and clinical development across multiple therapy areas in a number of companies. He is Fellow of Faculty of Pharmaceutical Medicine and holds an MBA from Surrey University. 

‘Faisal is the head of Global Risk Management in the WW R&D Organisation at Bristol Myers Squibb.  He has been in clinical development and medical affairs roles based out of the UK, France and the USA over the last 16 years with Sanofi, GSK & Novartis and was the Head of the European Medical Group at BMS before making the transition to his current role.  He graduated with a medical degree from Cambridge University and was a hospital doctor in the NHS with a focus in oncology & neurology prior to moving to industry.’

A pharmaceutical physician, with a CCST in Pharmaceutical medicine. An experienced medical affairs professional with a broad range of therapy area experience ranging from cardiovascular, Oncology and MS. Currently leads the Immunology medical team at BMS. Since joining, the industry has been instrumental in the successful launch of a first in class radiopharmaceutical Oncology product and a novel Ophthalmology molecule.

Janet have a background in immunology and epidemiology provides a strong scientific background combined with over 20 years’ practical experience in clinical research within the pharmaceutical industry.  This includes time spent in interventional clinical research, and decade in the observational study environment designing, executing and interpreting research projects requiring bespoke data capture as well as secondary use of existing data,.  I am passionate about the potential of real world evidence to inform, and where necessary help to change, clinical practice, with the over-arching aim being to benefit patients.  

This is an exciting time to be involved with real-world evidence generation: Technological advances in data capture and processing are advancing simultaneously with heightened awareness of the societal benefits of using health data and electronic health data for the public good, and greater acceptance of such use in a way that respects individual rights & privacy.

To be successful, publication of robust data obtained from scientifically rigorous research is essential; data that remain uninterrogated at source are no use to anyone.”

Teodora Festini, MD got her medical degree in Croatia, at University of Rijeka. She is an experienced medical affairs expert that worked with Abbott, Abbvie and currently Sandoz (Novartis division). She has been working on country, regional and global positions and is experienced in launch of several biologic products and indications. Her major focus of interest is maximizing medical affairs impact on transformation of healthcare landscape.

Michael Wiechmann is a German national living in Switzerland and a MD by training with specialization in internal medicine, haemato-oncology and medical informatics.

Early during his clinical training he experienced the power and potential of medical informatics to improve diagnostic processes and patient care. Since more than 20 years he is involved in the development and use of intelligent IT tools for predictive modeling, medical decision making and AI driven diagnostic support.

He also holds a MBA and PhD in health economics and business administration and is an active professor for strategy and health care management.

In his current role as Global Head Medical Affairs at Sandoz Biopharmaceuticals (a Novartis division) he is responsible for the entire spectrum of medical affairs with a special focus on strategic development, real world evidence generation and digitization of medical affairs. 

Prior to joining Sandoz, Michael founded a biotech company and has held several leadership positions in global medical affairs and management in pharma, biotech and health insurance companies.

Hatim is a Primary Care Physician in North West London, with experience in national healthcare policy, medical education and digital health. Hatim is one of the co-founders of the ‘Topol Programme for Digital Fellowships in Healthcare’ which provides health professionals with time, support and training to lead digital health transformations and innovations in their organisations. He is passionate about ensuring that healthcare professionals are prepared for and considered in the development of technologies which will impact on clinical practice and believes technology will massively change Primary and Community Healthcare in the future.  Hatim is a Senior Lecturer at Brunel University London, where he is leading the implementation of the first longitudinal approach to digital health within an undergraduate medical curriculum. Hatim provides the clinical leadership to the DART-Ed (Digital, AI and Robotics Technologies in Education) Programme at Health Education England, which looks to evaluate and prepare the National Health Service workforce preparedness for working effectively with these technologies.  

Dr Katerina Spranger is the Founder and CEO of the digital health startup Oxford Heartbeat, which has developed an innovative medical software called PreSize® Neurovascular that helps surgeons to rehearse and plan high-risk brain stenting surgeries more safely and accurately. PreSize enables surgeons to select the best-fit stent for each patient, with the aim of reducing surgical complications and improving patient outcomes. Oxford Heartbeat has received several important accolades, most recently the AI Health and Care Award in 2020 (NHSX and NIHR), which funds a pilot of PreSize at 6+ NHS Trusts. The company was also named by WIRED as the Best UK Healthcare Startup of 2018, and received the NHS Innovation Award in 2017. Katerina was named a “Founder Striving to Change the World” by Forbes in 2016, and a “Young Innovator of the Year” at Falling Walls Berlin 2013. She is also an Enterprise Fellow at The Royal Academy of Engineering, and holds a PhD in Engineering Science from the University of Oxford.

I am a research focussed clinical scientist, working in advanced imaging and image processing for radiotherapy.

My interests include translating cutting-edge methods into routine clinical practice and maximising patient benefit through digital technology, particularly artificial intelligence. Robustness is critical for novel digital technologies in the health sphere, to enable safe and effective uptake of AI.

My clinical work involves imaging patient motion during radiotherapy. Before changing career into radiotherapy I was a chemical physicist working in academic research. I enjoy the outdoors and live in Leeds with my wife and two boys.

George Harston is a Physician Scientist working between industry, academia and healthcare. George works as CMO (and leads Innovation) at Brainomix, a spinout company from the University of Oxford, developing and implementing AI-driven clinical support systems. He also works as a Consultant Physician in Stroke and Internal Medicine at Oxford University Hospitals NHSFT. George specialises in Stroke and Internal Medicine with an interest in real-world delivery of imaging biomarkers. George received his medical degree from the University of Cambridge in 2006. In 2015 George was awarded a DPhil (PhD) from the University of Oxford, following which he continued his research and clinical activity as Clinical Lecturer in the Acute Vascular Imaging Centre. His research centres on CT and MR imaging to better understand the pathophysiology of stroke and global brain injury.

Liz O’Riordan is an international speaker, broadcaster and award-winning co-author of ‘The Complete Guide to Breast Cancer: How to Feel Empowered and Take Control’ (Penguin) with Professor Trisha Greenhalgh.

In 2015 (aged 40) she was diagnosed with Stage 3 breast cancer whilst working as a Consultant Oncoplastic Breast Surgeon. In 2018 she had a locoregional recurrence on her chest wall. The side effects of treatment meant she had to retire as a surgeon in 2019. During chemotherapy she started an award-winning blog about her experiences (www.liz.oriordan.co.uk) and talks all over the world about how to improve patient care. She was nominated for a ‘Woman of the Year UK ’ award in 2016 and was one of Medscape’s Top 20 Doctors of 2018.

Liz has a keen interest in digital health and survivorship. She is also a keen sportswoman and is passionate about promoting the benefits of exercise for cancer patients.

I am a leader with a diverse background in managing different kinds of organisations and processes. Currently I am head of Product at Nectarine Health, working on increasing the health and security for elders living at home. In 2020 I left a CEO position where I executed a carve-out, development and successful exit cycle. I have extensive knowledge in software development, product management, project management, software development leadership, leadership team work, corporate board work, sales, sales leadership, marketing and marketing management. I have experience from startups, scale-ups and large corporations locally in Sweden but also internationally.My experiences as a product developer, culture bearer and empathic problem solver are my major assets. Working without prestige and at the speed of trust.

Mike is one of the UKs leading lifestyle medicine researchers and practitioners, publishing over 100 peer reviewed papers. He is Professor of Metabolism & Lifestyle Medicine at Newcastle University, founding director of the National Health Innovation Observatory (NIHR), a former National Institute for Health Research Senior Fellow and Diabetes UK RD Lawrence Fellow. Alongside being a holding roles on the EPSRC Healthcare Technologies Advisory board and past member of the Diabetes UK Science and Research Advisory Board, Mike is also a member of the editorial board of the American Diabetes Association journal ‘Diabetes’ and also ‘Clinical Science’.

Guy is a serial entrepreneur who has spent 20 years working in transformation across health and social care advising providers, commissioners and suppliers, working with DHSC and trade organisations on policy as well as valuation work in the health tech and infrastructure space for VC and PE. Most recently he has worked as a consultant and head of research with LaingBuisson (supplier of health and social care data to ONS) and is currently COO of Teladoc in the UK.  

Daniel Casson is a social care digital transformation and partnership building consultant. He works with innovators, social care providers, local authorities, the NHS, regulators and other health bodies to embed digital transformation and innovation in their everyday work. He works with the tech entrepreneurs and the Department for International Trade to guide innovation in social care. His areas of expertise include:

∙         digital transformation strategy in social care;

∙         creating value by digital transformation;

∙         integration of care and health;

∙         the use of data to enhance care & support,

 He is digital adviser at Care England, and is part of the Digital Social Care Team, working on the NHS Digital-financed programme to support care providers to transform digitally. He has worked closely with NHS Digital in guiding providers through the DSPT process and on how data collected in care organizations can be collated and analyzed on a local and regional level. He works with NHSX to embed digital transformation in social care as part of the Joining up Care Programme and has co-designed a cybersecurity training gap analysis.

 He writes a regular blog for Care England www.careengland.org.uk/digitalblog and co hosts the Talking Care podcast https://talking-care.com/. He is a governor of the Alder Hey Foundation Trust.

Sheena is the CEO and founder of Stress Point Health. She built the company from the ground up, with limited funding and a mission to lower the barriers to mental health treatment by digitising Neurofeedback, driven by her own experiences with PTSD.

Sheena is a seasoned international media and business professional who has spent her career fundraising and investing in the Technology, Media and Telecom sector, after building her foundations in the financial sector. Sheena has over 15 years of experience advising a range of clients on their strategic and financial growth, as well as fundraising in the media and technology sector, including Flick The Switch, FTS Capital, Procam, Mediatel and Numis Securities. She holds a bachelor’s degree from Cambridge University in land economy, and she has been selected for Cambridge Judge Business School Social Ventures 2017 Cohort.

Sheena is part of the Hatch Female Founders Accelerator Cohort 2020, recently voted one of the top 8 female focused accelerators in Europe. She is also a member of the British Association of Women Entrepreneurs.

Since joining the University of Manchester 15 years ago, informatics for mental health has been the principal focus of his research. He was the technical lead on the PsyGrid project (2005-2015) that developed the free, open source openCDMS system that was adopted for studies and trials across the Mental Health Research Network. He also developed  the ClinTouchapp  (2010 with Prof Shôn Lewis) for remote monitoring in schizophrenia, followed by the CareLoop Trial and more recently the EMPOWER Trial. Actissist (with Prof Sandra Bucci) delivering CBT via a smartphone app for recovery from psychosis has recently completed its second trial. John is the academic lead for the Greater Manchester Integrated Digital Care Record that links data across health services for the 2.8m citizens of Greater Manchester and has a current research portfolio with projects on learning health systems, IoT, blockchain and machine learning.

José Luis is Director and Associate Professorial Research Fellow at CPEC, LSE. He is also Director of the NIHR Policy Research Unit in Adult Social Care (ASCRU).

 A health and social care economist, José Luis specialises in ageing-related policies, the interaction between health and social care, and the economic evaluation of health and social care systems and services. He has been involved in several high-profile reviews of the social care funding system in England, as well as acting as specialist adviser to the House of Commons Health Select Committee’s Inquiry on social care.

In 2010, he co-founded the International Long-term care Policy Network (ILPN), which links academics and policy makers on the analysis of long-term care. He has also advised bodies such as the English Department of Health and Social Care, the UK Treasury, the European Commission, the Asian Development Bank, and the World Health Organization.

Charlotte is the Director for Mental Health at Oxehealth, who’s ambition is to help clinicians engineer ever better care for patients in hospital and nursing facilities.

Charlotte is working to help systematically raise the standard of care across mental health in the NHS. Her mission is to build lasting partnerships with providers to improve the safety, quality and experience for their patients when they are at their most vulnerable – in hospital – at the same time as delivering operational value for the NHS.

Four years into her time at Oxehealth, Charlotte and the team have a robust and growing evidence base, have supported almost 4 million hours of clinical care and are now working with 1-in-3 NHS England mental health trusts.

She started her career advising global healthcare businesses and their leaders on how to build digital products and transform their services through technology. She holds a Masters in Chemistry from Oxford University and International Public Policy & Public Health from UCL.

Matthew is the founder of Stigma Statistics, a social venture enabling real time visibility and insights on health, safety & suicide prevention. Their STAR platform is used in several STP’s for real time suicide surveillance. More recently they have started developing suicide behavioural monitoring technology using Internet of Things (IoT) beacons and telematic AI pattern matching through triangulation, which can alert to the presence of at risk behaviour and provide an opportunity to intervene, as well as intelligence around the event.

Jorge is a Physics graduate from Imperial College and holds a Masters in AI from the University of Barcelona. 

Having previously founded and directed an award-winning AI consultancy, he has designed and built chat and voice assistants for advance care planning.

Jorge has also implemented successful machine-learning algorithms for GPS-tracked on-demand delivery systems.

Paula Bellostas is a partner in Kearney’s Health and Digital Practices. She works with leading global biopharmaceutical companies at the intersection of medicine and technology to improve patient outcomes.

She came to consulting after a career as an industrial engineer, experience that helped mold her into the curious and analytical person she is today. But despite her background in a field driven by numbers, her approach to work is anything but impersonal. “Work hard, be kind and good things will happen,” she says, explaining her life philosophy.

Paula looks for ways to carry that ethos into her work every day. Consulting, she says, isn’t just about problem-solving; it’s about affecting clients in a positive way. “You’re doing something good for the client. The human-to-human connection is so important.”

Her favorite projects are those in which people are prepared to take risks and trust that you’re going to take that big leap side by side, she says. “You come at the problem as a team and then deliver a really good outcome.”

Paula is Kearney’s global mental health and wellbeing program lead, as well as a mental health advocate who volunteers with Samaritans, and her writing has been featured on Thrive Global and The Huffington Post.

Oliver spent six years as the Head of Public Health and Director of Strategy at the Health Authority, Abu Dhabi, before joining the Koa Health team to lead us in our pursuit of solutions for health, grounded in science.

Dr Pramod Prabhakaran joined Imperial College Health Partners in September 2016 to lead on international business development and partnerships. He has 18 years experience in clinical, educational and leadership roles in the NHS. Prior to joining the partnership, Pramod undertook various roles including Divisional Medical Director at Central & North West London NHS Foundation Trust and Co-director for undergraduate psychiatry at Imperial College School of Medicine.

Pramod has a background in primary care and mental health in the UK, India and Australia, and continues in clinical practice as a Consultant in the NHS. He has helped set up training programmes for international healthcare professionals and undertaken health policy research in conjunction with Beijing based, National Institute of Research. His current project involves analysis of healthcare utilisation and cost data for the elderly residents of Shanghai, with a view to developing cost-effective integrated solutions.

I am a registered clinical scientist working as a magnetic resonance physicist at Guy’s & St. Thomas’ NHS FT after having graduated from the NHS Scientist Training Programme.

Following a successful NHS Digital Pioneer Fellowship with DigitalHealth.London, I have recently been appointed as Digital Lead for the Clinical Imaging and Medical Physics directorate at my Trust, where we have begun work to develop an evaluation framework for clinical AI.

I am also a part-time PhD candidate at the Centre of Neuroimaging Sciences at King’s College London, developing a machine learning model to better evaluate treatment response in glioblastoma patients.

Sameena Ali-Khan anchors national bulletins for ITV at weekends, and throughout the week on Central Tonight in the Midlands, covering a wide range of stories across daily news and documentaries.

After studying Physiology and Chemistry, Sameena was drawn to journalism. After working on radio in Manchester she first appeared on air on BBC Radio Lancashire. She remained with the BBC, going back to Manchester and GMR before stints on the BBC Asian Network, BBC West Midlands and BBC London, as well Radio 5Live. On TV (aside from a debut appearance made whilst living in Nigeria on the country’s equivalent of Blue Peter) Sameena presented and reported for Northwest Today, Inside Out, and Midlands Today before moving to ITV.

With a presenting style combining bright and approachable with authoritative, Sameena is the only presenter to have won the RTS Best On Screen Personality two years running.

David Chung is the USA Head of Carewell Lepu Medical. A strategic partner of Intel Builders AI program. A patient turned AI technologist, an experienced manager with awareness of the application of digital technology in a range of sectors. David has worked in the healthcare IT sector since 2007, member of ALA, AHIMA leading strategic guidance on data backup, migration, business process outsource, reimbursement audit and workflow optimization.
Prior to Lepu Medical, he oversees millions of medical record data exchange in four States, responsible or $18M P&L as the technology transitioned into artificial intelligence processing. With diverse experience in the artificial intelligence legal services, he’s keen on the possibility of AI.
David is responsible for the global adoption of AI-ECG. And has successfully launched USA’s first AI-ECG enabled telemedicine platform, trained on 47 million patients heart ECG data.
With a sister that suffers from congenital heart disease. David is passionate on expanding the possibility of AI in challenging applications for better patient outcomes.

Joe has worked in healthcare IT since 2004 when he joined the first NHS Spine project as part of the National Programme for IT. He often says that since then he has been making up for the sins of the past. Today he advises everyone from the boards of the central NHS bodies to local charities and healthcare organisations on the best way to approach technology change and the best way to harness its potential to provide actual benefits for patients and health services.

Emma is an experienced innovation business leader, with proven track record of strategic and operational implementation of innovation methodology, services and cultural change within global small and large organisations. Emma is a collaborative, open communicator with 23 years international business experience, working since 2001 at the forefront of open innovation process development, understanding the importance of organisational, technical and commercial considerations for successful innovation strategy deployment.

Allison lectures at Keele University in Data Science and is a co-founder of Women Leading in AI, CEO of AI Aware and ForHumanity Fellow. Her research is focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI and health tech. She works on the IEEE P7003 Considerations of Algorithmic Systems and with the ISO and BSI on AI linked standards, sitting on the UK national committee for ART/01 Artificial Intelligence standards and on CEN-CENELEC JTC21. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant on the ethical design of autonomous and intelligent systems offering training and AI bias audits/AIAs.

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

Tarek R. Besold, PhD, is the Chief Behavioural Officer at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

At Alpha Health, Tarek offers strategic leadership at the intersection between AI, behavioural science, and the design of digital products. Tarek leads a team of 25 full-time engineers to identify opportunities where behavioural science could be applied to improve or change user behaviour in line with Alpha Health’s strategy and roadmap.

Before joining Telefonica Innovation Alpha, he was a Lecturer/Assistant Professor in Data Science at City, University of London, conducting research at the intersection between artificial intelligence, computational creativity, and cognitive systems.

Among others, Tarek was the General Chair of the HLAI 2016 and 2018 Joint Multi-Conferences on Human-Level Artificial Intelligence, and founder and organiser of several international workshop series bridging between AI and cognitive science. He was co-editor of the books Computational Creativity Research: Towards Creative Machines and Concept Invention: Foundations, Implementations, Social Aspects and Applications. In addition, Tarek holds different editorial functions with several scientific journals in AI and neighbouring fields (including Cognitive Systems Research and the Journal of Artificial General Intelligence).

Tarek also serves as chairman of the German Institute for Standardization (DIN)’s National Working Group on Standards and Norms for AI (part of the ISO/IEC JTC-1 SC 42 “Artificial Intelligence”), and as an expert member of the Digital Future Society’s Think Tank Working Group on “Data Ethics and the Challenge of Digital Privacy”.

Victoria has over a decade of experience in the semiconductor space. She currently heads up Strategic Partnerships at Graphcore, working with key customers and leading Research & Universities AI engagements. Previously she held several leadership positions at NVIDIA from global alliances, product marketing and campaigns to the founding of the GPU Technology Conference. Prior to joining NVIDIA, Victoria worked in the hedge fund space, as Executive Director for the Hedge Fund Business Operations Association. Victoria is a frequent contributor to ACM SIGGRAPH and is AR, MR & VR Chair for the SIGGRAPH 2019 Conference. She’s also an active member of the Consumer Technology Association’s AI Working Group.

Laurence Thorne is the policy manager for AI within NHSX and is supporting the development and delivery of the NHS AI Lab. Previously, Laurence has led the procurement and delivery of digital and transformation projects across government including in education, transport and health.

Dr Fanny Burrows is a Senior Programme Manager in the Innovation Team at LGC in the NIHR Central Commissioning Facility.
Fanny manages a portfolio of Invention for Innovation (i4i) projects and Small Business Research Initiative (SBRI) Healthcare projects. She also takes responsibilities for sourcing and managing expert members for the review panels and acts as a Patient and Public Involvement Lead.
Prior to working with the NIHR, Fanny spent a few years in a Medtech company, developing and transferring novel materials for applications in medical devices and focused on antimicrobial and haemocompatible coating technologies. Her work involved the research and development of biocompatible technologies, from feasibility stage to regulatory approval and market growth. Fanny was involved in a range of medium to large projects including technology transfer to global medical devices manufacturers.

Jo became involved in the AI Lab in January 2020 focusing on our first AI Health and Care Award. She does this alongside her role as head of office for the chairs of NHS England and NHS Improvement.
She has been working for the NHS for over 6 years now, originally from Australia where she studied both a Bachelor’s of Public Health and Health Promotion as well as a Bachelor of Commerce.
Jo worked in operational roles in Australia, focusing on opening café franchises from Dec 2011 until her move to the UK in July 2013 enjoying working with various stakeholders, building relationships and developing the franchise model.
She lives in Camberwell and loves the diversity and community of London.

With a keen interest in the potential of technology Dan joined NHSX in 2019 to lead implementation of the new NHS AI Lab.
Prior to this Dan spent 10 years managing government programmes including 6 years abroad with the Department for International Development in countries such as Afghanistan and the Democratic Republic of the Congo. Dan has specialised in implementing large health programmes in challenging environments and recently led the design and implementation of a £350m multi-donor programme providing basic health services in South Sudan. When not at work Dan enjoys tormenting his family with the latest smart home technology.

Data Partnerships Manager at the Wellcome Trust. Collaborating with data scientists, industry and academia to improve the way data is used in the health sector. Before joining the Wellcome Trust, dawn was a policy adviser at the ODI and help deliver many of our international projects including the Open Data Leaders Network. Dawn is an ODI Registered Trainer with expertise in expertise in data, community building and policy making.

Featured as ‘one to watch’ in a list of top black women working in the UK tech industry as part of the #wherearethefaces initiative.

Reema is a programme manager at the Nuffield Foundation, and is working to establish the Ada Lovelace Institute, an organisation seeking to ensure that data & AI work for people and society. She is an experienced policy professional who has led various citizen engagement and participation initiatives on complex and controversial policy areas in the UK, including the Royal Society of Arts (RSA) Citizens’ Economic Council, which successfully worked with and influenced the Bank of England’s public engagement strategy. Reema has consulted for a variety of international organisations, including the Danish Board of Technology Foundation and Nextdoor.com, San Francisco based technology social media start-up. She is a fellow of the RSA, founding trustee of a community run library, and a local councillor.

Dr Harvey is a radiologist, trained in the NHS and Europe’s leading cancer research institute, the ICR, where he was twice awarded Science Writer of the Year. Previously a consultant radiologist at Guys & St Thomas’, he has held senior positions at two leading AI startups, sat on several national committees for AI in radiology in the UK, and acted as co-chair of the government-commissioned Topol Review into the impact of AI in the NHS. He is currently managing director at digital health consultancy Hardian Health focussed on clinical, regulatory and financial services for the technology sector.